Mirum Pharmaceuticals's total assets for Q3 2024 were $667.89M, an increase of 1.08% from the previous quarter. MIRM total liabilities were $435.87M for the fiscal quarter, a 0.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.